Evidence map›Paper›PMID 41334309›Full record

ArticleJournal of current ophthalmology

Structural and Microvascular Characteristics of Branch Retinal Vein Occlusion Eyes with and without Retinal Atrophy following Macular Edema Resolution.

Ayna Sariyeva Ismayilov, Ramazan Burak Can, Muhammed Yelkovan, Mahmut Oguz Ulusoy

Abstract read
In one paragraph

Article in Journal of current ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ayna Sariyeva IsmayilovDepartment of Ophthalmology, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.
Ramazan Burak CanDepartment of Ophthalmology, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.
Muhammed YelkovanDepartment of Ophthalmology, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.
Mahmut Oguz UlusoyDepartment of Ophthalmology, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate the baseline optical coherence tomography (OCT) and OCT angiography (OCTA) characteristics of patients with branch retinal vein occlusion (BRVO) who developed retinal atrophy following the resolution of macular edema (ME). A secondary objective is to assess the relationship between these baseline imaging parameters and final visual acuity (VA). Methods: This retrospective cohort study analyzed 65 eyes of 65 patients diagnosed with BRVO-related ME. All patients received three loading doses of intravitreal anti-vascular endothelial growth factor treatment based on their ME and VA status; intravitreal injections were administered. Patients were divided into two groups; Group 1 included eyes with complete resolution of ME with retinal atrophy, and Group 2 included eyes without retinal atrophy. Group 1 patients were further divided into those with good and poor VA. Results: The baseline central retinal thickness (CRT) was significantly higher ( Conclusions: Higher baseline CRT, lower baseline CCT, and lower quadrantal SCP VD were found in BRVO patients with retinal atrophy. However, higher DCP VD and less ischemia at baseline are predictive of better visual outcomes even in the presence of retinal atrophy. These findings may highlight the prognostic value of OCT and OCTA parameters in the treatment of BRVO.

Indexed as

Branch retinal vein occlusionOptical coherence tomographyOptical coherence tomography angiographyRetinal atrophy

Identifiers

PMID41334309
PMCPMC12668643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.